Art

J-GLOBAL ID：202402255161708780   Reference number：24A0398629

Improved DNA Vaccine Delivery with Needle-Free Injection Systems

ニードルフリーインジェクションシステムによる改善されたDNAワクチンデリバリー【JST・京大機械翻訳】

Author (8)： Ledesma-Feliciano Carmen (PharmaJet, 400 Corporate Circle, Unit N, Golden, CO 80401, USA) ,  Chapman Ros (Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa) ,  Chapman Ros (Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa) ,  Hooper Jay W. (Molecular Virology Branch, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702, USA) ,  Elma Kira (PharmaJet, 400 Corporate Circle, Unit N, Golden, CO 80401, USA) ,  Zehrung Darin (PharmaJet, 400 Corporate Circle, Unit N, Golden, CO 80401, USA) ,  Brennan Miles B. (ZabBio, Inc., 11760 Sorrento Valley Road, San Diego, CA 92121, USA) ,  Spiegel Erin K. (PharmaJet, 400 Corporate Circle, Unit N, Golden, CO 80401, USA)
Material： Vaccines (Web)
Volume： 11  Issue： 2  Page： 280  Publication year： 2023 
JST Material Number： U7290A  ISSN： 2076-393X  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： DNA vaccines have inherent adv...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=24A0398629&from=J-GLOBAL&jstjournalNo=U7290A") }}

Thesaurus term： safety ,  *DNA ,  adjuvant ,  heredity ,  antigen ,  cell ,  syringe ,  *vaccine ,  immunogenicity ,  cell physiology ,  virus vaccine ,  electroporation ,  *DNA vaccine
Semi thesaurus term： 免疫系 ,  防衛 ,  ワクチン抗原 ,  細胞取込 , 【Automatic Indexing@JST】

Author keywords (10)： needle-free injection ,  jet injection ,  DNA ,  DNA vaccines ,  viral vaccines ,  electroporation ,  gene gun ,  particle-mediated epidermal delivery ,  pandemic viruses ,  emerging infectious diseases

JST classification (1)： Basic research of immunotherapeutic agents and blood preparations  (GW22010D)

Reference (97)：

• Shafaati, M.; Saidijam, M.; Soleimani, M.; Hazrati, F.; Mirzaei, R.; Amirheidari, B.; Tanzadehpanah, H.; Karampoor, S.; Kazemi, S.; Yavari, B.; et al. A brief review on DNA vaccines in the era of COVID-19. Future Virol. 2022, 17, 49-66.
• Eusebio, D.; Neves, A.R.; Costa, D.; Biswas, S.; Alves, G.; Cui, Z.; Sousa, A. Methods to improve the immunogenicity of plasmid DNA vaccines. Drug Discov. Today 2021, 26, 2575-2592.
• Li, L.; Petrovsky, N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev. Vaccines 2016, 15, 313-329.
• Kutzler, M.A.; Weiner, D.B. DNA vaccines: Ready for prime time? Nat. Rev. Genet. 2008, 9, 776-788.
• Suschak, J.J.; Williams, J.A.; Schmaljohn, C.S. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Hum. Vaccines Immunother. 2017, 13, 2837-2848.

Terms in the title (2)： DNAワクチン ,  デリバリー